Facing COVID-19 with the benefits of medical cannabis

Since 2020 we have been in a pandemic that has affected our lives in multiple ways. Schools, businesses, religious institutions, and even government agencies have closed their doors in response to the effects of the coronavirus. That is why even today the most common question remains, what can we do to face the causes and consequences of COVID-19? Although opinions are polarized around the world regarding the progress of vaccines, there is a millenary use that has helped to prevent and confront diseases that affect the immune system of human beings: the therapeutic power of plants.

Due to the interest in natural compounds derived from plants, Cannabis sativa L. is a plant species with agronomic, industrial, and medical relevance, and has been used since the beginning of mankind. It has more than 500 compounds, including cannabinoids, terpenes, fatty acids, and flavonoids. Phytocannabinoids (known as cannabis-derived compounds) have been presenting medical and industrial prominence in recent decades. The Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the most relevant phytocannabinoids due to their therapeutic characteristics and have been shown to play an important role in the treatment of various physiological and psychological conditions, helping to counteract infectious diseases caused by pathogenic microorganisms.

In this audiobook Pharmacology University brings you how cannabis can influence the improvement and relief of symptoms caused by the SARS-CoV-2 virus, understanding the importance of the endocannabinoid system in the regulation of the immune system, the mechanisms of action of phytocannabinoid compounds in the treatment of the disease caused by COVID-19 and the sequelae caused by it.

© 2022 Pharmacology University (Audiolibro ): 9781669694281

Fecha de lanzamiento

Audiolibro : 27 de marzo de 2022